Bioadhesive nanoparticles (white) after being taken up by skin cancer tumor cells during in vitro culture.
(Image credit: Julia Lewis)
Yale researchers are developing a skin cancer treatment that involves injecting nanoparticles into the tumor, killing cancer cells with a two-pronged approach, as a potential alternative to surgery.
“For a lot of patients, treating skin cancer is much more involved than it would be if there was a way to effectively treat them with a simple procedure like an injection,” said Dr. Michael Girardi, professor and vice chair of dermatology at Yale School of Medicine and senior author of the study. “That’s always been a holy grail in dermatology — to find a simpler way to treat skin cancers such as basal cell carcinoma and squamous cell carcinoma.”
For the treatment, tumors are injected with polymer-based nanoparticles carrying a chemotherapy agent. Key to the treatment’s success is that the nanoparticles are bioadhesive — that is, they bind to the tumors and remain attached long enough to kill a significant number of the cancer cells.
“When you inject our nanoparticles into a tumor, it turns out that they’re retained within that tumor very well,” said co-author Mark Saltzman, the Goizueta Foundation Professor of Biomedical Engineering, Chemical and Environmental Engineering, and professor of physiology. “They accumulate and bind to the tumor matrix, so one single injection lasts for a very long time — the particles stay there and slowly release the compounds. You need that to get rid of the lesion.”
For comparison, the same drug was injected freely into tumors of control models without the nanoparticles. They found that the tumors were significantly more diminished when the drugs were delivered by nanoparticles.
Also critical to the therapy is that the treatment can be combined with an agent that stimulates the body’s immune system.
“I call the phenomenon ‘kill and thrill,’” Girardi said. “You don’t want to just kill the cells and leave them there, you want to stimulate the immune system to clean up the mess and also react against cells that might not have been killed directly. So it’s a two-pronged attack on the cancer.”
In many cases, ridding tumors with an injection could eliminate the need for surgery, the researchers said. It may also then avoid potential wound infections and other complications. Additionally, some patients with other medical conditions are poor candidates for surgery.
An injection-based therapy would also mean that patients could have multiple tumors treated in a single visit.
“In these studies, we did just a single injection, and that’s how we’d like it to work clinically,” Saltzman said. “You go to a dermatologist, they see a lesion and inject into it, and it’s gone and you don’t have to come back.”
Saltzman’s lab, which specializes in nanoparticles, worked to optimize the particles’ drug-carrying ability to deliver as much of the chemotherapy agent in a single dose as possible. Because the contents of the nanoparticle remain at the site of the tumor, the delivery system allows for the use of particularly powerful drugs. Conventional chemotherapy affects the entire body and can have severe side effects, so the toxicity of drugs is more limited.
Original Article: Yale researchers develop injection to treat skin cancer
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Sean Lock death – Comedian ‘left family £3M’ as friend Bill Bailey says he ‘laughed until end’ before lung cancer deathon August 22, 2021 at 6:31 am
COMEDIAN Sean Lock’s cause of death was lung cancer, his friend Bill Bailey revealed. The Eight Out of 10 cats legend passed away earlier this week surrounded by family, sparking tributes ...
- Spotting the Signs of Deadly Melanoma Skin Cancerson August 22, 2021 at 6:00 am
Regular skin checks to look for signs of melanoma could save your life. Self-exams for the deadliest type of skin cancer should be done at least once a month in a well-lit room in front of a ...
- Memoir offers intimate portrayal of one woman’s journey through skin canceron August 22, 2021 at 1:00 am
In 'Skin,' Maine writer Kate Kennedy tackles her diagnosis and treatment with a purposeful – and defiant – precision.
- ESPN analyst Dick Vitale has melanoma skin cancer removed: 'I was a little shook up'on August 21, 2021 at 2:46 pm
ESPN college basketball analyst Dick Vitale had a patch of melanoma, a form of skin cancer, removed from just above his nose.
- Legendary ESPN Broadcaster Dick Vitale Reveals Skin Cancer Diagnosis, Patient With Cancer Receives COVID-19 Booster Shot and Moreon August 20, 2021 at 8:00 am
From Dick Vitale’s early melanoma cancer detection to the authorization of COVID-19 vaccine booster shots for patients with cancer, here’s what’s happening in the cancer landscape this week.
Go deeper with Google Headlines on:
Go deeper with Bing News on:
Injection to treat skin cancer
- Zydus Cadila launches blood thinner in the USon August 19, 2021 at 11:45 pm
Cadila Healthcare said it has launched a generic blood thinning medication, Enoxaparin Sodium Injection, in the US, where the drug has annual sales of around $513 mn, or around Rs 3,800 cr. With this, ...
- Scancell Hlds - Scancell selects PharmaJet’s Needle-free Systemson August 17, 2021 at 11:42 am
Scancell selects PharmaJet's clinically proven Needle-free Systems for COVID-19 vaccine trial. Preclinical studies confirm that PharmaJet delivery ...
- Scancell selects PharmaJet’s Needle-free Systemson August 16, 2021 at 11:00 pm
Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, today announces that it has selected the PharmaJet Needle-free Injection ...
- Westlake’s Virbac Announces Availability of New Dog Cancer Treatment Across the U.S.on August 16, 2021 at 5:14 pm
Stelfonta received FDA approval last November to treat dogs with non-metastatic, skin-based mast cell tumors (MCTs)—the most common malignant skin tumor in dogs. The injection is now available at vet ...
- Virbac Announces FDA Approval of New Cancer Treatment for Dogs Derived from Australian Rainforest Planton August 16, 2021 at 4:25 am
Virbac announces the breakthrough drug STELFONTA® (tigilanol tiglate injection) that has been approved by the U.S. Food and Drug ...